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Background: Direct stent implantation is associated with more favorable clinical and angiographic results in STEMI patients.This benefit is less 
clear among the remaining ACS population.
Methods: Single center,retrospective registry including all ACS Non ST Elevation patients (P) (Non STEMI:107 P and Unstable Angina:75 P) treated 
from January 2007 to December 2009.We exclude patients with culprit lesion in a restenotic segment and SVG lesions.Patients were divided 
in 2 groups according to the strategy to deploy the stent (direct vs pre dilatation) which was at operator´s discretion.The primary goal was the 
comparison of clinical outcomes at one year.
Results: 182 P were enrolled being direct stent performed in 78 P.The mean age of the population was 61±11 years with 67% of male and 33,5% 
of diabetics (no significant difference between groups).Pre dilatation cohort had more frequently type C lesions (36.5% vs 17.9%,p= 0.006),smaller 
reference vessel diameter (2.34±0.68 vs 2.68±0.62,p = 0.0001) and tighter lesions (MLD of 0.5±0.38mm vs 0.77±0.55, p=0.001).Moderate/
severe calcification was noticed in 13.2% of the cases equally distribute in both groups.There were no differences in the occurrence of peri-
procedural angiographic complications -no-reflow,distal embolization or occlusion of side branches- and in achieving TIMI 3 flow after the procedure 
between patients with direct stenting vs pre dilatation (5.1% vs 8.7%,p=0.36 and 98.7% vs 95.2%,p=0.24,respectively).In-hospital combined major 
adverse cardiac events (MACE) rate (death,myocardial infarction and need for urgent target vessel revascularization) was equal between groups 
(11.5% vs 11.5%,p=1.00),but the strategy direct stenting was associated with a trend to less non-Q wave MI (0% vs 4.8%,p= 0.06).One-year MACE 
rate was also similar between groups (14.1% vs 13.5%,p=1.00).
Conclusions: In this series of non STEMI ACS patients,the decision for direct stenting was not associated with significant improvement in 
angiogaphic and clinical outcomes despite a trend to less peri procedure MI among those individuals.However,lesion complexity remains as the 
main determinant of the strategy to pre dilatate in the real world practice.
